{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:23:25Z","timestamp":1785536605013,"version":"3.56.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-010104"],"award-info":[{"award-number":["INV-010104"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Gambiense<\/jats:italic>\n                      human African trypanosomiasis (gHAT) has been brought under control recently with village-based active screening playing a major role in case reduction. In the approach to elimination, we investigate how to optimise active screening in villages in the Democratic Republic of Congo, such that the expenses of screening programmes can be efficiently allocated whilst continuing to avert morbidity and mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We implement a cost-effectiveness analysis using a stochastic gHAT infection model for a range of active screening strategies and, in conjunction with a cost model, we calculate the net monetary benefit (NMB) of each strategy. We focus on the high-endemicity health zone of Kwamouth in the Democratic Republic of Congo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>High-coverage active screening strategies, occurring approximately annually, attain the highest NMB. For realistic screening at 55% coverage, annual screening is cost-effective at very low willingness-to-pay thresholds (&lt;DOLLAR\/&gt;20.4 per disability adjusted life year (DALY) averted), only marginally higher than biennial screening (&lt;DOLLAR\/&gt;14.6 per DALY averted). We find that, for strategies stopping after 1, 2 or 3 years of zero case reporting, the expected cost-benefits are very similar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We highlight the current recommended strategy\u2014annual screening with three years of zero case reporting before stopping active screening\u2014is likely cost-effective, in addition to providing valuable information on whether transmission has been interrupted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-021-01943-4","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T15:02:47Z","timestamp":1617289367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2665-0127","authenticated-orcid":false,"given":"Christopher N.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kat S.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Antill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick Mwamba","family":"Miaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt J.","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"1943_CR1","unstructured":"World Health Organization. WHO Global Health Observatory. https:\/\/www.who.int\/data\/gho. Accessed 17 Nov 2020."},{"issue":"5","key":"1943_CR2","doi-asserted-by":"publisher","first-page":"0008261","DOI":"10.1371\/journal.pntd.0008261","volume":"14","author":"JR Franco","year":"2020","unstructured":"Franco JR, Cecchi G, Priotto G, Paone M, Diarra A, Grout L, Simarro PP, Zhao W, Argaw D. Monitoring the elimination of human african trypanosomiasis at continental and country level: Update to 2018. PLoS Negl Trop Dis. 2020; 14(5):0008261.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"1943_CR3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1371\/journal.pntd.0001691","volume":"6","author":"V Jamonneau","year":"2012","unstructured":"Jamonneau V, Ilboudo H, Kabor\u00e9 J, Kaba D, Koffi M, Solano P, Garcia A, Courtin D, Laveissi\u00e8re C, Lingue K, et al. Untreated human infections by trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis. 2012; 6(6):1691.","journal-title":"PLoS Negl Trop Dis"},{"key":"1943_CR4","volume-title":"GBD Compare Data Visualization","author":"Institute for Health Metrics and Evaluation (IHME)","year":"2020","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington; 2020. Available from http:\/\/vizhub.healthdata.org\/gbd-compare. (Accessed 2020)."},{"key":"1943_CR5","first-page":"1","volume":"(984)","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Control and surveillance of human African trypanosomiasis. World Health Organ Tech Rep Ser. 2013; (984):1\u2013237. PMID: 24552089.","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"6","key":"1943_CR6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1017\/S0031182013002102","volume":"141","author":"J Franco","year":"2014","unstructured":"Franco J, Simarro P, Diarra A, Ruiz-Postigo J, Jannin J. The journey towards elimination of gambiense human african trypanosomiasis: not far, nor easy. Parasitology. 2014; 141(6):748\u201360.","journal-title":"Parasitology"},{"issue":"5","key":"1943_CR7","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1365-3156.2004.01240.x","volume":"9","author":"J Robays","year":"2004","unstructured":"Robays J, Bilengue MMC, Stuyft P. V. d., Boelaert M. The effectiveness of active population screening and treatment for sleeping sickness control in the democratic republic of congo. Trop Med Int Health. 2004; 9(5):542\u201350.","journal-title":"Trop Med Int Health"},{"issue":"10110","key":"1943_CR8","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","volume":"390","author":"P B\u00fcscher","year":"2017","unstructured":"B\u00fcscher P, Cecchi G, Jamonneau V, Priotto G. Human African trypanosomiasis. Lancet. 2017; 390(10110):2397\u2013409.","journal-title":"Lancet"},{"issue":"1","key":"1943_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12942-015-0013-9","volume":"14","author":"C Lumbala","year":"2015","unstructured":"Lumbala C, Simarro PP, Cecchi G, Paone M, Franco JR, Mesu VKBK, Makabuza J, Diarra A, Chansy S, Priotto G, et al. Human african trypanosomiasis in the democratic republic of the congo: disease distribution and risk. Int J Health Geogr. 2015; 14(1):20.","journal-title":"Int J Health Geogr"},{"key":"1943_CR10","first-page":"103","volume":"58","author":"E Magnus","year":"1978","unstructured":"Magnus E, Van Meirvenne N, Vervoort T, Le Ray D, W\u00e9ry M, Others. Use of freeze-dried trypanosomes in the indirect fluorescent antibody test for the serodiagnosis of sleeping sickness. Ann Soc Belg M\u00e9d Trop. 1978; 58:103\u20139.","journal-title":"Ann Soc Belg M\u00e9d Trop"},{"issue":"9","key":"1943_CR11","doi-asserted-by":"publisher","first-page":"e0204335","DOI":"10.1371\/journal.pone.0204335","volume":"13","author":"PR Bessell","year":"2018","unstructured":"Bessell PR, Lumbala C, Lutumba P, Baloji S, Bieler S, Ndung\u2019u JM. Cost-effectiveness of using a rapid diagnostic test to screen for human african trypanosomiasis in the democratic republic of the congo. PLoS ONE. 2018; 13(9):e0204335.","journal-title":"PLoS ONE"},{"issue":"10","key":"1943_CR12","doi-asserted-by":"publisher","first-page":"e0186429","DOI":"10.1371\/journal.pone.0186429","volume":"12","author":"C Wamboga","year":"2017","unstructured":"Wamboga C, Matovu E, Bessell PR, Picado A, Bi\u00e9ler S, Ndung\u2019u JM. Enhanced passive screening and diagnosis for gambiense human african trypanosomiasis in north-western uganda\u2013moving towards elimination. PLoS ONE. 2017; 12(10):e0186429.","journal-title":"PLoS ONE"},{"issue":"1","key":"1943_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-018-0472-x","volume":"7","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Palmer JJ. Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in uganda\u2019s human african trypanosomiasis elimination programme. Infect Dis Poverty. 2018; 7(1):1\u201316.","journal-title":"Infect Dis Poverty"},{"issue":"6","key":"1943_CR14","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/tmi.12102","volume":"18","author":"D Mumba Ngoyi","year":"2013","unstructured":"Mumba Ngoyi D, Menten J, Pyana PP, B\u00fcscher P, Lejon V. Stage determination in sleeping sickness: Comparison of two cell counting and two parasite detection techniques. Trop Medi Int Health. 2013; 18(6):778\u201382.","journal-title":"Trop Medi Int Health"},{"issue":"10116","key":"1943_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0140-6736(18)30019-9","volume":"391","author":"F Chappuis","year":"2018","unstructured":"Chappuis F. Oral fexinidazole for human african trypanosomiasis. The Lancet. 2018; 391(10116):100\u20132.","journal-title":"The Lancet"},{"key":"1943_CR16","unstructured":"WHO interim guidelines for the treatment of gambiense human African trypanosomiasis. Geneva: World Health Organization; 2019. PMID: 31449367."},{"key":"1943_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1051\/parasite\/2016059","volume":"23","author":"M Koffi","year":"2016","unstructured":"Koffi M, N\u2019Djetchi M, Ilboudo H, Kaba D, Coulibaly B, N\u2019Gouan E, Kouakou L, Bucheton B, Solano P, Courtin F, et al. A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in C\u00f4te d\u2019Ivoire. Parasite. 2016; 23:51.","journal-title":"Parasite"},{"issue":"1","key":"1943_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/tmi.12404","volume":"20","author":"P Mitashi","year":"2015","unstructured":"Mitashi P, Hasker E, Mbo F, Van Geertruyden J, Kaswa M, Lumbala C, Boelaert M, Lutumb a. P.Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the democratic republic of the congo. Trop Med Int Health. 2015; 20(1):98\u2013105.","journal-title":"Trop Med Int Health"},{"key":"1943_CR19","volume-title":"Progress in Human African Trypanosomiasis, Sleeping Sickness","author":"S Van Nieuwenhove","year":"1999","unstructured":"Van Nieuwenhove S. Present strategies in the treatment of human African trypanosomiasis. In: Progress in Human African Trypanosomiasis, Sleeping Sickness. Paris: Springer: 1999. p. 253\u201380."},{"issue":"4-5","key":"1943_CR20","first-page":"441","volume":"61","author":"P Simarro","year":"2001","unstructured":"Simarro P, Franco J, Asumu PN. Has the focus of human African trypanosomiasis in Luba, Equatorial Guinea been eradicated?. Med Trop revue du Corps de sante colonial. 2001; 61(4-5):441\u20134.","journal-title":"Med Trop revue du Corps de sante colonial"},{"issue":"1","key":"1943_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13071-015-1121-x","volume":"8","author":"A Pandey","year":"2015","unstructured":"Pandey A, Atkins KE, Bucheton B, Camara M, Aksoy S, Galvani AP, Ndeffo-Mbah ML. Evaluating long-term effectiveness of sleeping sickness control measures in Guinea. Parasites Vectors. 2015; 8(1):550.","journal-title":"Parasites Vectors"},{"issue":"1","key":"1943_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13071-015-1131-8","volume":"8","author":"KS Rock","year":"2015","unstructured":"Rock KS, Torr SJ, Lumbala C, Keeling MJ. Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the DRC. Parasites Vectors. 2015; 8(1):532.","journal-title":"Parasites Vectors"},{"issue":"9","key":"1943_CR23","doi-asserted-by":"publisher","first-page":"e1005103","DOI":"10.1371\/journal.pcbi.1005103","volume":"12","author":"H De Vries","year":"2016","unstructured":"De Vries H, Wagelmans AP, Hasker E, Lumbala C, Lutumba P, De Vlas SJ, van de Klundert J. Forecasting human african trypanosomiasis prevalences from population screening data using continuous time models. PLoS Comput Biol. 2016; 12(9):e1005103.","journal-title":"PLoS Comput Biol"},{"key":"1943_CR24","doi-asserted-by":"publisher","first-page":"0005162","DOI":"10.1371\/journal.pntd.0005162","volume":"11","author":"KS Rock","year":"2017","unstructured":"Rock KS, Torr SJ, Lumbala C, Keeling MJ. Predicting the impact of intervention strategies for sleeping sickness in two high-endemicity health zones of the Democratic Republic of Congo. PLoS Negl Trop Dis. 2017; 11:0005162.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"1943_CR25","doi-asserted-by":"publisher","first-page":"0005792","DOI":"10.1371\/journal.pntd.0005792","volume":"11","author":"MH Mahamat","year":"2017","unstructured":"Mahamat MH, Peka M, Rayaisse J. -b., Rock KS, Toko MA, Darnas J, Brahim GM, Alkatib AB, Yoni W, Tirados I, Courtin F, Brand SPC, Nersy C, Alfaroukh O, Torr SJ, Lehane MJ, Solano P. Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad). PLoS Negl Trop Dis. 2017; 11(7):0005792.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"1943_CR26","doi-asserted-by":"publisher","first-page":"e0007838","DOI":"10.1371\/journal.pntd.0007838","volume":"13","author":"CN Davis","year":"2019","unstructured":"Davis CN, Rock KS, Miaka EM, Keeling MJ. Village-scale persistence and elimination of gambiense human african trypanosomiasis. PLoS Negl Trop Dis. 2019; 13(10):e0007838.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"1943_CR27","doi-asserted-by":"publisher","first-page":"e0007903","DOI":"10.1371\/journal.pntd.0007903","volume":"13","author":"ML Ndeffo-Mbah","year":"2019","unstructured":"Ndeffo-Mbah ML, Pandey A, Atkins KE, Aksoy S, Galvani AP. The impact of vector migration on the effectiveness of strategies to control gambiense human african trypanosomiasis. PLoS Negl Trop Dis. 2019; 13(12):e0007903.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1943_CR28","doi-asserted-by":"publisher","first-page":"0007976","DOI":"10.1371\/journal.pntd.0007976","volume":"14","author":"MS Casta\u00f1o","year":"2020","unstructured":"Casta\u00f1o MS, Ndeffo-Mbah ML, Rock KS, Palmer C, Knock E, Miaka EM, Ndung\u2019u JM, Torr S, Verl\u00e9 P, Spencer SE, et al. Assessing the impact of aggregating disease stage data in model predictions of human african trypanosomiasis transmission and control activities in bandundu province (drc). PLoS Negl Trop Dis. 2020; 14(1):0007976.","journal-title":"PLoS Negl Trop Dis"},{"issue":"03","key":"1943_CR29","doi-asserted-by":"publisher","first-page":"20145847","DOI":"10.1101\/2020.07.03.20145847","volume":"07","author":"C-I Huang","year":"2020","unstructured":"Huang C-I, Crump RE, Brown P, Spencer SE, Miaka EM, Shampa C, Keeling MJ, Rock KS. Shrinking the ghat map: identifying target regions for enhanced control of gambiense human african trypanosomiasis in the democratic republic of congo. medRxiv. 2020; 07(03):20145847. https:\/\/doi.org\/10.1101\/2020.07.03.20145847.","journal-title":"medRxiv"},{"issue":"1","key":"1943_CR30","doi-asserted-by":"publisher","first-page":"e1008532","DOI":"10.1371\/journal.pcbi.1008532","volume":"17","author":"RE Crump","year":"2021","unstructured":"Crump RE, Huang C-I, Knock ES, Spencer SEF, Brown PE, Mwamba Miaka E, et al.Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo. PLoS Comput Biol. 2021; 17(1):e1008532. https:\/\/doi.org\/10.1371\/journal.pcbi.1008532.","journal-title":"PLoS Comput Biol"},{"key":"1943_CR31","unstructured":"The World Bank. Data: Democratic Republic of Congo. 2015. http:\/\/data.worldbank.org\/country\/congo-democratic-republic. Accessed 2015."},{"issue":"1","key":"1943_CR32","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1371\/journal.pntd.0001467","volume":"6","author":"A Mpanya","year":"2012","unstructured":"Mpanya A, Hendrickx D, Vuna M, Kanyinda A, Lumbala C, Tshilombo V, Mitashi P, Luboya O, Kande V, Boelaert M, Lef\u00e9vre P, Lutumba P. Should I get screened for sleeping sickness? A qualitative study in Kasai province. PLoS Negl Trop Dis. 2012; 6(1):1467.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1943_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1017\/S0031182000066853","volume":"97","author":"D Rogers","year":"1988","unstructured":"Rogers D. A general model for the African trypanosomiases. Parasitology. 1988; 97(1):193\u2013212.","journal-title":"Parasitology"},{"issue":"1","key":"1943_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2334-8-16","volume":"8","author":"F Checchi","year":"2008","unstructured":"Checchi F, Filipe JAN, Haydon DT, Chandramohan D, Chappuis F. Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect Dis. 2008; 8(1):16.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1943_CR35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13104-015-1244-3","volume":"8","author":"F Checchi","year":"2015","unstructured":"Checchi F, Funk S, Chandramohan D, Haydon DT, Chappuis F. Updated estimate of the duration of the meningo-encephalitic stage in gambiense human African trypanosomiasis. BMC Res Notes. 2015; 8(1):292.","journal-title":"BMC Res Notes"},{"issue":"4","key":"1943_CR36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1017\/S0031182010001496","volume":"138","author":"S Davis","year":"2011","unstructured":"Davis S, Aksoy S, Galvani A. A global sensitivity analysis for African sleeping sickness. Parasitology. 2011; 138(4):516\u201326.","journal-title":"Parasitology"},{"issue":"2","key":"1943_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0001-706X(03)00191-8","volume":"88","author":"S Ravel","year":"2003","unstructured":"Ravel S, Gr\u00e9baut P, Cuisance D, Cuny G. Monitoring the developmental status of Trypanosoma brucei gambiense in the tsetse fly by means of PCR analysis of anal and saliva drops. Acta Trop. 2003; 88(2):161\u20135.","journal-title":"Acta Trop"},{"issue":"2","key":"1943_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1046\/j.1365-2915.1998.00097.x","volume":"12","author":"P Clausen","year":"1998","unstructured":"Clausen P, Adeyemi I, Bauer B, Breloeer M, Salchow F, Staak C. Host preferences of tsetse (Diptera: Glossinidae) based on bloodmeal identifications. Med Vet Entomol. 1998; 12(2):168\u201380.","journal-title":"Med Vet Entomol"},{"issue":"7","key":"1943_CR39","doi-asserted-by":"publisher","first-page":"e1233","DOI":"10.1371\/journal.pntd.0001233","volume":"5","author":"F Checchi","year":"2011","unstructured":"Checchi F, Chappuis F, Karunakara U, Priotto G, Chandramohan D. Accuracy of five algorithms to diagnose gambiense human african trypanosomiasis. PLoS Negl Trop Dis. 2011; 5(7):e1233.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"1943_CR40","doi-asserted-by":"publisher","first-page":"0003785","DOI":"10.1371\/journal.pntd.0003785","volume":"9","author":"PP Simarro","year":"2015","unstructured":"Simarro PP, Cecchi G, Franco JR, Paone M, A D, Priotto G, R M, J J. Monitoring the progress towards the elimination of gambiense human African trypanosomiasis. PLoS Negl Trop Dis. 2015; 9(6):0003785.","journal-title":"PLoS Negl Trop Dis"},{"key":"1943_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1476-072X-9-57","volume":"9","author":"PP Simarro","year":"2010","unstructured":"Simarro PP, Cecchi G, Jannin JG. The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geogr. 2010; 9:57.","journal-title":"Int J Health Geogr"},{"key":"1943_CR42","unstructured":"World Health Organization, Baltussen RMPM, Adam T, Tan-Torres Edejer T, Hutubessy RCW, et al.Making choices in health : WHO guide to costeffectiveness analysis \/ edited by T. Tan-Torres Edejer... [et al]. World Health Organization. 2003. https:\/\/apps.who.int\/iris\/handle\/10665\/42699."},{"issue":"2","key":"1943_CR43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3201\/eid1302.060075","volume":"13","author":"P Lutumba","year":"2007","unstructured":"Lutumba P, Makieya E, Shaw A, Meheus F, Boelaert M. Human african trypanosomiasis in a rural community, democratic republic of congo. Emerg Infect Dis. 2007; 13(2):248.","journal-title":"Emerg Infect Dis"},{"key":"1943_CR44","unstructured":"Indicators WD. World bank. Technical report. 2015. https:\/\/datacatalog.worldbank.org\/dataset\/world-development-indicators. Accessed 2020."},{"issue":"10159","key":"1943_CR45","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0140-6736(18)32335-3","volume":"392","author":"HH Kyu","year":"2018","unstructured":"Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, Abbastabar H, Abd-Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national disability-adjusted life-years (dalys) for 359 diseases and injuries and healthy life expectancy (hale) for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018; 392(10159):1859\u2013922.","journal-title":"Lancet"},{"issue":"12","key":"1943_CR46","doi-asserted-by":"publisher","first-page":"0008832","DOI":"10.1371\/journal.pntd.0008832","volume":"14","author":"R Snijders","year":"2020","unstructured":"Snijders R, Fukinsia A, Claeys Y, Mpanya A, Hasker E, Meheus F, Miaka EM, Boelaert M. Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2020; 14(12):0008832.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"1943_CR47","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3201\/eid1310.060358","volume":"13","author":"P Lutumba","year":"2007","unstructured":"Lutumba P, Meheus F, Robays J, Miaka C, Kande V, B\u00fcscher P, Dujardin B, Boelaert M. Cost-effectiveness of algorithms for confirmation test of human african trypanosomiasis. Emerg Infect Dis. 2007; 13(10):1484.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"1943_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.vaccine.2015.10.045","volume":"34","author":"M Irurzun-Lopez","year":"2016","unstructured":"Irurzun-Lopez M, Erondu NA, Djibo A, Griffiths U, Stuart JM, Fernandez K, Ronveaux O, Le Gargasson J-B, Gessner BD, Colombini A. The actual and potential costs of meningitis surveillance in the african meningitis belt: Results from chad and niger. Vaccine. 2016; 34(8):1133\u20138.","journal-title":"Vaccine"},{"issue":"1","key":"1943_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12962-017-0083-6","volume":"15","author":"MY Bertram","year":"2017","unstructured":"Bertram MY, Stenberg K, Brindley C, Li J, Serje J, Watts R, Edejer TT-T. Disease control programme support costs: an update of who-choice methodology, price databases and quantity assumptions. Cost Eff Resour Allocation. 2017; 15(1):21.","journal-title":"Cost Eff Resour Allocation"},{"issue":"1","key":"1943_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12962-018-0095-x","volume":"16","author":"K Stenberg","year":"2018","unstructured":"Stenberg K, Lauer JA, Gkountouras G, Fitzpatrick C, Stanciole A. Econometric estimation of who-choice country-specific costs for inpatient and outpatient health service delivery. Cost Eff Resour Allocation. 2018; 16(1):11.","journal-title":"Cost Eff Resour Allocation"},{"key":"1943_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.actatropica.2015.06.003","volume":"150","author":"J Keating","year":"2015","unstructured":"Keating J, Yukich JO, Sutherland CS, Woods G, Tediosi F. Human African trypanosomiasis prevention, treatment and control costs: A systematic review. Acta Trop. 2015; 150:4\u201313.","journal-title":"Acta Trop"},{"issue":"4-5","key":"1943_CR52","first-page":"412","volume":"61","author":"A Shaw","year":"2001","unstructured":"Shaw A, Cattand P. Analytical tools for planning cost-effective surveillance in gambiense sleeping sickness. Med Trop revue du Corps de sante colonial. 2001; 61(4-5):412\u201321.","journal-title":"Med Trop revue du Corps de sante colonial"},{"issue":"10116","key":"1943_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","volume":"391","author":"VKBK Mesu","year":"2018","unstructured":"Mesu VKBK, Kalonji WM, Bardonneau C, Mordt OV, Blesson S, Simon F, Delhomme S, Bernhard S, Kuziena W, Lubaki J-PF, et al. Oral fexinidazole for late-stage african trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. Lancet. 2018; 391(10116):144\u201354.","journal-title":"Lancet"},{"issue":"1","key":"1943_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2214-109X(16)30237-6","volume":"5","author":"CS Sutherland","year":"2017","unstructured":"Sutherland CS, Stone CM, Steinmann P, Tanner M, Tediosi F. Seeing beyond 2020: an economic evaluation of contemporary and emerging strategies for elimination of Trypanosoma brucei gambiense. Lancet Glob Health. 2017; 5(1):69\u201379.","journal-title":"Lancet Glob Health"},{"key":"1943_CR55","doi-asserted-by":"publisher","unstructured":"Antillon M, Huang C-I, Crump RE, Brown PE, Snijders R, Miaka EM, Keeling MJ, Rock KS, Tediosi F. Economic evaluation of gambiense human African trypanosomiasis elimination campaigns in five distinct transmission settings in the Democratic Republic of Congo. medRxiv. 2020. 2020.08.25.20181982; https:\/\/doi.org\/10.1101\/2020.08.25.20181982.","DOI":"10.1101\/2020.08.25.20181982"},{"issue":"2","key":"1943_CR56","doi-asserted-by":"publisher","first-page":"e2704","DOI":"10.1371\/journal.pntd.0002704","volume":"8","author":"F Hackett","year":"2014","unstructured":"Hackett F, Ford LB, Fevre E, Simarro P. Incorporating scale dependence in disease burden estimates: the case of human african trypanosomiasis in uganda. PLoS Negl Trop Dis. 2014; 8(2):e2704.","journal-title":"PLoS Negl Trop Dis"},{"key":"1943_CR57","unstructured":"Chang W, Cheng J, Allaire J, Xie Y, McPherson J. shiny: Web Application Framework for R. R package version 1.5.0. 2020. https:\/\/CRAN.R-project.org\/package=shiny."},{"issue":"4","key":"1943_CR58","doi-asserted-by":"publisher","first-page":"0008033","DOI":"10.1371\/journal.pntd.0008033","volume":"14","author":"MR Behrend","year":"2020","unstructured":"Behrend MR, Bas\u00e1\u00f1ez M-G, Hamley JI, Porco TC, Stolk WA, Walker M, de Vlas SJ, NTD Modelling Consortium. Modelling for policy: The five principles of the neglected tropical diseases modelling consortium. PLoS Negl Trop Dis. 2020; 14(4):0008033.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"1943_CR59","doi-asserted-by":"publisher","first-page":"0006890","DOI":"10.1371\/journal.pntd.0006890","volume":"12","author":"JR Franco","year":"2018","unstructured":"Franco JR, Cecchi G, Priotto G, Paone M, Diarra A, Grout L, Simarro PP, Zhao W, Argaw D. Monitoring the elimination of human African trypanosomiasis: Update to 2016. PLoS Negl Trop Dis. 2018; 12(12):0006890.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1943_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgh-2018-001173","volume":"4","author":"CS Sutherland","year":"2019","unstructured":"Sutherland CS, Tediosi F. Is the elimination of sleeping sickness\u2019 affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa. BMJ Glob Health. 2019; 4(2):1\u201311.","journal-title":"BMJ Glob Health"},{"key":"1943_CR61","first-page":"257","volume":"6","author":"JR Franco","year":"2014","unstructured":"Franco JR, Simarro PP, Diarra A, Jannin JG. Epidemiology of human african trypanosomiasis. Clin Epidemiol. 2014; 6:257.","journal-title":"Clin Epidemiol"},{"issue":"10","key":"1943_CR62","doi-asserted-by":"publisher","first-page":"1004514","DOI":"10.1371\/journal.pcbi.1004514","volume":"11","author":"CM Stone","year":"2015","unstructured":"Stone CM, Chitnis N. Implications of heterogeneous biting exposure and animal hosts on trypanosomiasis brucei gambiense transmission and control. PLoS Comput Biol. 2015; 11(10):1004514.","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"1943_CR63","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","volume":"12","author":"PG Kennedy","year":"2013","unstructured":"Kennedy PG. Clinical features, diagnosis, and treatment of human african trypanosomiasis (sleeping sickness). Lancet Neurol. 2013; 12(2):186\u201394.","journal-title":"Lancet Neurol"},{"key":"1943_CR64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fcimb.2013.00084","volume":"3","author":"LR Haines","year":"2013","unstructured":"Haines LR. Examining the tsetse teneral phenomenon and permissiveness to trypanosome infection. Front Cell Infect Microbiol. 2013; 3:84.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1943_CR65","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13071-018-2922-5","volume":"11","author":"MC Stanton","year":"2018","unstructured":"Stanton MC, Esterhuizen J, Tirados I, Betts H, Torr SJ. The development of high resolution maps of tsetse abundance to guide interventions against human African trypanosomiasis in northern Uganda. Parasites Vectors. 2018; 11(1):340.","journal-title":"Parasites Vectors"},{"issue":"Supplement_5","key":"1943_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/infdis\/jiz588","volume":"221","author":"MS Casta\u00f1o","year":"2020","unstructured":"Casta\u00f1o MS, Aliee M, Mwamba Miaka E, Keeling MJ, Chitnis N, Rock KS. Screening strategies for a sustainable endpoint for gambiense sleeping sickness. J Infect Dis. 2020; 221(Supplement_5):539\u201345.","journal-title":"J Infect Dis"},{"issue":"6","key":"1943_CR67","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/tmi.12483","volume":"20","author":"P Steinmann","year":"2015","unstructured":"Steinmann P, Stone CM, Sutherland CS, Tanner M, Tediosi F. Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: Review. Trop Medi Int Health. 2015; 20(6):707\u201318.","journal-title":"Trop Medi Int Health"},{"issue":"1","key":"1943_CR68","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/08039410.1993.9665939","volume":"20","author":"RA Lea","year":"1993","unstructured":"Lea RA. World Development Report 1993: \u2018Investing in Health\u2019. Forum Dev Stud. 1993; 20(1):114\u20137.","journal-title":"Forum Dev Stud"},{"issue":"3","key":"1943_CR69","first-page":"429","volume":"72","author":"C Murray","year":"1994","unstructured":"Murray C. Quantifying the burden of disease : the technical basis for disability-adjusted life years. Bull World Health Organ. 1994; 72(3):429\u201345.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"1943_CR70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1478-7547-1-8","volume":"1","author":"R Hutubessy","year":"2003","unstructured":"Hutubessy R, Chisholm D, Edejer TT-T. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Effect Resour Allocation. 2003; 1(1):8.","journal-title":"Cost Effect Resour Allocation"},{"issue":"7","key":"1943_CR71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.jval.2017.12.016","volume":"21","author":"AA Leech","year":"2018","unstructured":"Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and misuse of cost-effectiveness analysis thresholds in low-and middle-income countries: trends in cost-per-daly studies. Value Health. 2018; 21(7):759\u201361.","journal-title":"Value Health"},{"issue":"8","key":"1943_CR72","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","volume":"19","author":"B Woods","year":"2016","unstructured":"Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: Initial estimates and the need for further research. Value Health. 2016; 19(8):929\u201335.","journal-title":"Value Health"},{"issue":"6","key":"1943_CR73","doi-asserted-by":"publisher","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","volume":"3","author":"J Ochalek","year":"2018","unstructured":"Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data. BMJ Glob health. 2018; 3(6):e000964.","journal-title":"BMJ Glob health"},{"issue":"July","key":"1943_CR74","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2471\/BLT.15.164418","volume":"94","author":"MY Bertram","year":"2016","unstructured":"Bertram MY, Lauer JA, Joncheere KD, Edejer T, Hutubessy R, Kieny P, Hill SR, Bertram MY. Cost \u2013 effectiveness thresholds: pros and cons Use and misuse of thresholds. Bull World Health Organ. 2016; 94(July):925\u201330.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"1943_CR75","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2471\/BLT.14.138206","volume":"93","author":"E Marseille","year":"2015","unstructured":"Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost\u2013effectiveness of interventions: Alternative approaches. Bull World Health Organ. 2015; 93(2):118\u201324.","journal-title":"Bull World Health Organ"},{"issue":"38","key":"1943_CR76","doi-asserted-by":"publisher","first-page":"9616","DOI":"10.1073\/pnas.1807915115","volume":"115","author":"RJ Wall","year":"2018","unstructured":"Wall RJ, Rico E, Lukac I, Zuccotto F, Elg S, Gilbert IH, Freund Y, Alley MRK, Field MC, Wyllie S, Horn D. Clinical and veterinary trypanocidal benzoxaboroles target CPSF3. Proc Natl Acad Sci USA. 2018; 115(38):9616\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1943_CR77","unstructured":"The World Bank. GDP per capita (current US<DOLLAR\/>) - Congo, Dem. Rep. World Bank national accounts data, and OECD National Accounts data files. 2018. https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=CD (Accessed 2020)."},{"issue":"1","key":"1943_CR78","first-page":"11","volume":"68","author":"F Louis","year":"2008","unstructured":"Louis F, Kohagne LT, Ebo\u2019O VE, Simarro P. Organizing an active screening campaign for human African trypanosomiasis due to Trypanosoma brucei gambiense. M\u00e9d Trop revue du Corps de sant\u00e9 colonial. 2008; 68(1):11\u201316.","journal-title":"M\u00e9d Trop revue du Corps de sant\u00e9 colonial"},{"issue":"14","key":"1943_CR79","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1017\/S0031182009006416","volume":"136","author":"S Welburn","year":"2009","unstructured":"Welburn S, Maudlin I, Simarro P. Controlling sleeping sickness\u2013a review. Parasitology. 2009; 136(14):1943\u20139.","journal-title":"Parasitology"},{"issue":"8","key":"1943_CR80","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/hec.635","volume":"10","author":"E Fenwick","year":"2001","unstructured":"Fenwick E, Claxton K, Sculpher M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ. 2001; 10(8):779\u201387.","journal-title":"Health Econ"},{"issue":"5","key":"1943_CR81","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1524-4733.2008.00358.x","volume":"11","author":"GR Barton","year":"2008","unstructured":"Barton GR, Briggs AH, Fenwick EAL. Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value Health. 2008; 11(5):886\u201397.","journal-title":"Value Health"},{"issue":"1","key":"1943_CR82","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s13071-015-1235-1","volume":"8","author":"TD Hollingsworth","year":"2015","unstructured":"Hollingsworth TD, Adams ER, Anderson RM, Atkins K, Bartsch S, Bas\u00e1\u00f1ez M-g, Behrend M, Blok DJ, Chapman LAC, Coffeng L, Courtenay O, Crump RE, Vlas SJD, Dobson A, Dyson L, Farkas H, Galvani AP, Gambhir M, Gurarie D, Irvine MA, Jervis S, Keeling MJ, Kelly-hope L, King C, Lee BY, Rutte EAL, Lietman TM, Ndeffo-mbah M, Medley GF, Michael E, Pandey A, Peterson JK, Pinsent A, Porco TC, Richardus JH, Reimer L, Rock KS, Singh BK, Stolk W, Swaminathan S, Torr SJ, Townsend J, Truscott J, Walker M, Zoueva A, Consortium NTDM. Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasites Vectors. 2015; 8(1):630.","journal-title":"Parasites Vectors"},{"issue":"12","key":"1943_CR83","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1371\/journal.pntd.0001950","volume":"6","author":"E Hasker","year":"2012","unstructured":"Hasker E, Lutumba P, Chappuis F, Kande V, Potet J, De Weggheleire A, Kambo C, Depoortere E, Pecoul B, Boelaert M. Human african trypanosomiasis in the democratic republic of the congo: a looming emergency?. PLoS Negl Trop Dis. 2012; 6(12):1950.","journal-title":"PLoS Negl Trop Dis"},{"key":"1943_CR84","volume-title":"Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data","author":"JM Ochalek","year":"2015","unstructured":"Ochalek JM, Lomas J, Claxton KP. Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data. York: Centre for Health Economics, University of York; 2015, pp. 1\u201350. (CHE Research Paper; 122)."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-01943-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-021-01943-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-01943-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T15:07:02Z","timestamp":1617289622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-01943-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":84,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-01943-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.03.20167296","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"18 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}